5-Amino-1MQ 5MG
$120.00
5-Amino-1MQ 5MG is a 5-milligram format of 5-Amino-1MQ, a small molecule commonly used in research as an NNMT inhibitor. Researchers study NNMT inhibition in the context of cellular NAD metabolism, methylation pathways, and metabolic regulation. Studies have examined 5-Amino-1MQ in preclinical systems focused on adipose biology and energy balance.
In Stock
5-Amino-1MQ 5MG is a 5-milligram format of 5-Amino-1MQ, a small molecule widely referenced in research involving nicotinamide N-methyltransferase (NNMT) inhibition. NNMT is a cytosolic enzyme that catalyzes the methylation of nicotinamide, connecting nicotinamide handling to broader methyl-donor and NAD related pathways.
In laboratory settings, 5-Amino-1MQ 5MG is of interest for studies examining how NNMT activity may relate to metabolic signaling, adipocyte function, and cellular energetics in preclinical models. Researchers also use NNMT inhibitors to probe links between nicotinamide metabolism and epigenetic methylation capacity, depending on the experimental system.
- Specification: 5MG
This product is intended for laboratory and research purposes only. Not for human consumption.
| Weight | 0.2 kg |
|---|---|
| Dimensions | 5 × 5 × 5 cm |
Related Products
Winstrol 50mg ml 10ml refers to stanozolol at a labeled concentration of 50 mg per mL in a 10 mL format. Stanozolol is a synthetic anabolic androgenic steroid derived from dihydrotestosterone, commonly referenced in analytical and sports doping research. Researchers may examine it in studies involving androgen receptor signaling, steroid metabolism, and assay validation.
In Stock
Winstrol 50mg/ml 10ml refers to a 50 milligram per millilitre, 10 millilitre format commonly associated with stanozolol, a synthetic anabolic androgenic steroid. In research settings, stanozolol has been examined for its interactions with androgen receptor signaling and anabolic androgenic structure activity relationships. Studies have also used it as a reference compound in analytical and anti doping method development.
In Stock
Trenbolone Acetate 75Mg, Trenbolone Enanthate 125Mg – 200mg/ml, 10 ml is a combined format of trenbolone in two ester forms: acetate and enanthate. Trenbolone is a synthetic anabolic androgenic steroid derived from 19-nortestosterone and widely referenced in endocrine and receptor binding research. Studies have examined esterified trenbolone in the context of androgen receptor signaling, pharmacokinetics, and steroid structure activity relationships.
In Stock
Trenbolone Enanthate (Tre) 100mg/ml 10ml is an oil based preparation of trenbolone enanthate, a synthetic anabolic androgenic steroid ester derived from 19 nor testosterone chemistry. Researchers may reference trenbolone esters in studies involving androgen receptor signaling, nitrogen balance models, and steroid pharmacokinetics. This format is commonly discussed in analytical and method development work where concentration and volume are specified.
In Stock
Semaglutide 2MG is a 2-milligram format of semaglutide, a synthetic GLP 1 receptor agonist peptide analogue. It is studied in pharmacology and metabolic research as a long acting incretin mimetic. Researchers examine semaglutide in receptor signaling and glucose homeostasis models.
In Stock
Tirzepatide 30MG is a 30-milligram format of tirzepatide, a synthetic peptide investigated as a dual GIP and GLP 1 receptor agonist in metabolic research. Studies have examined tirzepatide in the context of incretin signaling, glucose regulation pathways, and energy balance models.
In Stock
Semaglutide 15MG is a 15-milligram format of semaglutide, a synthetic peptide analogue of the endogenous incretin hormone GLP 1. Researchers study semaglutide as a GLP 1 receptor agonist in models of glucose regulation, appetite signaling, and cardiometabolic physiology.
In Stock
Tirzepatide 10MG is a 10-milligram format of tirzepatide, a synthetic peptide investigated as a dual GIP and GLP 1 receptor agonist in metabolic research. Studies have examined tirzepatide in the context of incretin signaling, glycemic physiology, and energy balance pathways.
In Stock
Tirzepatide 15MG is a 15-milligram format of tirzepatide, a synthetic peptide studied as a dual agonist at the GIP and GLP 1 receptors. It is of interest in metabolic and endocrine research where incretin signaling is examined. Studies have evaluated tirzepatide in preclinical and clinical settings to better understand receptor bias, signaling kinetics, and downstream biomarker changes.
In Stock
Trenbolone Enanthate (Tre) 200mg/ml 10ml is a concentration and volume format of trenbolone enanthate, a synthetic anabolic androgenic steroid and esterified analogue of trenbolone. Researchers may use trenbolone esters in laboratory work involving androgen receptor signaling, steroid metabolism, and analytical reference testing.
In Stock
Masteron / Drostanolone Propionate 100mg/ml 10ml is a preparation of drostanolone propionate, an androgenic anabolic steroid derived from dihydrotestosterone. Researchers may reference drostanolone in studies involving androgen receptor signaling and steroid structure activity relationships. It is also encountered in analytical work focused on identification, profiling, and method development for anabolic agents.
In Stock
Superdrol / Methyldrostanolone 50mg/ml, 10ml refers to a defined concentration and volume format of methyldrostanolone, a 17 alpha alkylated synthetic anabolic androgenic steroid related to dihydrotestosterone analogues. Researchers have examined methyldrostanolone in studies of androgen receptor activity and anabolic androgenic structure activity relationships.
In Stock
